Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAN KONG LEUNG

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1184760969
CMS profile
281203
Location
PLEASANTON, CA

General Payments · PY2018–2024

$6,971.10

  • Reported across 326 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$939.29

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $939.29 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
UCB, Inc. $361.83 16
ABBVIE INC. $180.22 7
Axsome Therapeutics, Inc. $104.25 4
PFIZER INC. $93.14 4
Lilly USA, LLC $65.96 2
Lundbeck LLC $28.68 1
Neurelis, Inc. $28.47 1
Octapharma USA, Inc. $26.60 1
Otsuka America Pharmaceutical, Inc. $25.85 1
Sumitomo Pharma America, Inc. $24.29 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,219.75 60
PY2019 $1,698.06 98
PY2020 $436.41 22
PY2021 $610.08 28
PY2022 $867.41 35
PY2023 $1,200.10 45
PY2024 $939.29 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.08 01/09/2024 Food and Beverage Undisputed 01/23/2026 1104164916 CMS
ABBVIE INC. $30.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 1104164918 CMS
ABBVIE INC. $27.65 03/28/2024 Food and Beverage Undisputed 01/23/2026 1104164920 CMS
ABBVIE INC. $20.79 05/01/2024 Food and Beverage Undisputed 01/23/2026 1104164922 CMS
ABBVIE INC. $28.12 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104164924 CMS
ABBVIE INC. $27.86 09/18/2024 Food and Beverage Undisputed 01/23/2026 1104164926 CMS
ABBVIE INC. $24.72 10/24/2024 Food and Beverage Undisputed 01/23/2026 1104164928 CMS
Axsome Therapeutics, Inc. $32.72 01/18/2024 Food and Beverage Undisputed 01/23/2026 1148300380 CMS
Axsome Therapeutics, Inc. $23.89 05/02/2024 Food and Beverage Undisputed 01/23/2026 1148300382 CMS
Axsome Therapeutics, Inc. $23.69 07/11/2024 Food and Beverage Undisputed 01/23/2026 1148300384 CMS
Axsome Therapeutics, Inc. $23.95 09/26/2024 Food and Beverage Undisputed 01/23/2026 1148300386 CMS
Lilly USA, LLC $31.94 02/06/2024 Food and Beverage Undisputed 01/23/2026 1135163589 CMS
Lilly USA, LLC $34.02 11/12/2024 Food and Beverage Undisputed 01/23/2026 1135103247 CMS
Lundbeck LLC $28.68 10/30/2024 Food and Beverage Undisputed 01/23/2026 1145939120 CMS
Neurelis, Inc. $28.47 10/31/2024 Food and Beverage Undisputed 01/23/2026 1145646523 CMS
Octapharma USA, Inc. $26.60 09/19/2024 Food and Beverage Undisputed 01/23/2026 1142316473 CMS
Otsuka America Pharmaceutical, Inc. $25.85 04/24/2024 Food and Beverage Undisputed 01/23/2026 1118929944 CMS
PFIZER INC. $22.28 04/25/2024 Food and Beverage Undisputed 01/23/2026 1131337469 CMS
PFIZER INC. $21.21 08/22/2024 Food and Beverage Undisputed 01/23/2026 1131893032 CMS
PFIZER INC. $23.37 10/08/2024 Food and Beverage Undisputed 01/23/2026 1132085704 CMS
PFIZER INC. $26.28 10/29/2024 Food and Beverage Undisputed 01/23/2026 1132100809 CMS
Sumitomo Pharma America, Inc. $24.29 02/22/2024 Food and Beverage Undisputed 01/23/2026 1148881098 CMS
UCB, Inc. $2.48 01/25/2024 Food and Beverage Undisputed 01/23/2026 1143060085 CMS
UCB, Inc. $32.26 01/25/2024 Food and Beverage Undisputed 01/23/2026 1143060087 CMS
UCB, Inc. $25.69 03/05/2024 Food and Beverage Undisputed 01/23/2026 1143060089 CMS
UCB, Inc. $26.28 04/09/2024 Food and Beverage Undisputed 01/23/2026 1143060091 CMS
UCB, Inc. $30.94 05/09/2024 Food and Beverage Undisputed 01/23/2026 1143060093 CMS
UCB, Inc. $26.49 06/05/2024 Food and Beverage Undisputed 01/23/2026 1143060095 CMS
UCB, Inc. $26.28 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143060097 CMS
UCB, Inc. $30.33 08/21/2024 Food and Beverage Undisputed 01/23/2026 1143060099 CMS
UCB, Inc. $1.90 09/04/2024 Food and Beverage Undisputed 01/23/2026 1143060101 CMS
UCB, Inc. $31.41 09/04/2024 Food and Beverage Undisputed 01/23/2026 1143060103 CMS
UCB, Inc. $27.13 09/17/2024 Food and Beverage Undisputed 01/23/2026 1143060105 CMS
UCB, Inc. $1.90 10/02/2024 Food and Beverage Undisputed 01/23/2026 1143060107 CMS
UCB, Inc. $31.99 10/02/2024 Food and Beverage Undisputed 01/23/2026 1143060109 CMS
UCB, Inc. $34.76 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143060111 CMS
UCB, Inc. $10.77 11/20/2024 Food and Beverage Undisputed 01/23/2026 1143060113 CMS
UCB, Inc. $21.22 11/20/2024 Food and Beverage Undisputed 01/23/2026 1143060115 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.